Aperture Therapeutics Email Format
Biotechnology ResearchUnited States2-10 Employees
Aperture Therapeutics is a biotechnology company developing a new class of therapeutics to treat injury- and age-induced neurodegeneration. The company's innovative platform leverages insight into disease resilience from large genomic and clinical data with streamlined drug discovery platform that generates drugs mimicking the effects of protective human gene variants.